Peptide-Nucleic Acid Complexes for Cellular Delivery
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for delivering anionic substances, such as nucleic acids, into cells for therapeutic applications face inefficiencies due to polyanionic nature limiting membrane passage and endosomal retention, leading to reduced therapeutic effectiveness.
Innovation Solution
A peptide with specific amino acid sequences, capable of membrane disruption and nucleic acid binding, forms complexes with anionic substances to enhance cellular uptake and escape from endosomal retention, utilizing a molar ratio optimized for efficient transfection.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Ease of operation
If anionic substances (nucleic acids) are delivered directly into cells, then the polyanionic nature of nucleic acids limits membrane passage, but using cationic lipids or polymers to facilitate entry causes endosomal retention
Solution Approach 1:
The patent uses cell-penetrating peptides (CPPs) as intermediary carriers that facilitate nucleic acid entry into cells without causing endosomal retention. The peptides form transient complexes with the anionic nucleic acids, enabling membrane passage through a mechanism that avoids the endosomal pathway problematic with cationic lipids and polymers.
Solution Approach 2:
The invention changes the physical-chemical parameters of the delivery system by using short peptides (5-50 amino acids) with specific properties (positive charge density, amphipathic character) rather than large cationic polymers or lipids. This parameter change enables membrane penetration while avoiding endosomal trapping.
2Productivity
If viral vectors are used for delivery, then transfection efficiency is improved, but immune response concerns and rapid clearance from circulation occur
Solution Approach 1:
The patent employs short-lived, non-integrating peptide-nucleic acid complexes that perform their delivery function and are then naturally degraded. These transient complexes avoid the persistent immune activation and long-term safety concerns associated with viral vectors, while still achieving effective transfection.
Solution Approach 2:
The cell-penetrating peptides utilize the cell's own endocytic machinery and natural degradation pathways for delivery, rather than forcing entry through viral mechanisms that trigger immune responses. The system harnesses existing cellular processes for its benefit.
3Ease of manufacture
If naked RNA or DNA is injected directly into cells, then some transfection occurs, but efficiency remains very limited due to polyanionic nature
Solution Approach 1:
The invention creates a composite delivery system combining cell-penetrating peptides with nucleic acids. The peptide component provides membrane-interaction capabilities while the nucleic acid provides the therapeutic payload, creating a material with properties superior to either component alone.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The peptide-anionic substance complexes demonstrate improved transfection efficiency and therapeutic effect by facilitating the delivery of nucleic acids into the cytoplasm or nucleus, overcoming previous limitations of endosomal retention and membrane passage.
Implementation Method 1
A peptide with specific amino acid sequences, capable of membrane disruption and nucleic acid binding, forms complexes with anionic substances
Implementation Method 2
A peptide with specific amino acid sequences, capable of membrane disruption and nucleic acid binding
Implementation Method 3
escape from endosomal retention, utilizing a molar ratio optimized for efficient transfection
Data Source
AI summary
The present invention relates to compositions and methods for the delivery of an anionic substance using complexes, comprising the anionic substance and a peptide. These complexes are useful for delivering said anionic substance into a cell, particularly in therapeutic applications.